Julie Harper, MD, and Hilary Baldwin, MD: Acne and Rosacea Treatment Updates

Drs. Julie Harper and Hilary Baldwin shared insights on shifting practices for acne and rosacea. Dr. Harper explained that topical acne treatments have become effective enough to serve as a first-line therapy before considering oral antibiotics, while topical retinoids and scar procedures can now be safely used alongside isotretinoin. For rosacea, Dr. Baldwin emphasized that targeted treatments are required for distinct symptoms like erythema or papules, often necessitating combination therapy. She also highlighted using modified-release tetracyclines to achieve anti-inflammatory benefits without contributing to antibiotic resistance during long-term care.

MORE MAUI DERM NP+PA FALL 2026 CONFERENCE COVERAGE:

Willa Hsueh, MD: GLP-1 Receptor Agonists for Obesity and Associated Complications

Dr. Willa Hsueh highlights GLP-1 receptor agonists as blockbuster treatments for obesity, type 2 diabetes, and various associated health issues. To manage common gastrointestinal side

Alisa Femia, MD: Emerging Advances in Dermatomyositis Treatment

Dr. Alisa Femia focuses on dermatomyositis, a condition characterized by photosensitivity, severe skin itch, muscle weakness, and internal organ involvement. The speaker outlines traditional and

Abrar Qureshi, MD, MPH: New Developments and Therapies in Rare Diseases in Dermatology

Dr. Abrar Qureshi highlights new and upcoming therapies across complex skin conditions, including subcutaneous anifrolumab and litifilimab for cutaneous lupus, alongside brepocitinib, the first approved

Alisa Femia, MD: Cutting-Edge Therapies for Cutaneous Lupus

Dr. Alisa Femia provides a recap of her conference presentation covering emerging treatments for cutaneous lupus. She notes that standard first-line management involves potent topical

G. Michael Lewitt, MD: Overview of Atopic Dermatitis and Itch Treatment Options and Considerations

Dr. Michael Lewitt presented on current and emerging treatments for skin conditions like atopic dermatitis and itch. He opened the panel by discussing FDA-approved drugs

Alexandra Charrow, MD: Key Takeaways on Managing Hidradenitis Suppurativa

Dr. Alexandra Charrow presents insights from her presentation on managing challenging cases of hidradenitis suppurativa. She notes that clinicians often wait too long to initiate

Matthew Zirwas, MD: Dermatology Literature Highlights

Dr. Matthew Zirwas breaks down recent updates in dermatology literature presented during his conference session. He notes some of the least painful injectable biologics for

David Oberlin, MD: Impractically Practical Procedural Pearls in Dermatologic Surgery

Dr. David Oberlin presented on practical procedural tips for dermatologic surgery. He developed this content to address a gap in training for nurse practitioners and

Kara Mudd, DMSc, MSPAS, PA-C: Insights on Eczematous Dermatosis and Patch Testing

Kara Mudd, DMSc, MSPAS, PA-C, stresses the importance of reconsidering a diagnosis or opting for patch testing when a patient’s rash fails to respond to